Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/24/21
End: 06/02/27
Due: 06/02/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Evaluate VT3989 in Patients with Metastatic Solid Tumors | NCT04665206 | Vivace Therapeutics, Inc | user2@example.com | None | 2021-03-24 | 2027-06-02 | 2028-06-02 | - | - | 2025-07-14 |